[go: up one dir, main page]

IE872860L - Therapeutic compositions and use thereof - Google Patents

Therapeutic compositions and use thereof

Info

Publication number
IE872860L
IE872860L IE872860A IE286087A IE872860L IE 872860 L IE872860 L IE 872860L IE 872860 A IE872860 A IE 872860A IE 286087 A IE286087 A IE 286087A IE 872860 L IE872860 L IE 872860L
Authority
IE
Ireland
Prior art keywords
therapeutic compositions
isopropylamino
pyrrol
phenoxy
propanol
Prior art date
Application number
IE872860A
Other languages
English (en)
Original Assignee
Kent Elgaard Poulsen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH4235/86A external-priority patent/CH668185A5/de
Application filed by Kent Elgaard Poulsen filed Critical Kent Elgaard Poulsen
Publication of IE872860L publication Critical patent/IE872860L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333Radicals substituted by oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IE872860A 1986-10-24 1987-10-23 Therapeutic compositions and use thereof IE872860L (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH4235/86A CH668185A5 (de) 1986-10-24 1986-10-24 Verwendung von 1-isopropylamino-3-(o-(1-pyrrolyl)-phenoxy)-2-propanol zur herstellung von pharmazeutischen praeparaten.
CH17887 1987-01-19
CH92687 1987-03-12
CH92587 1987-03-12

Publications (1)

Publication Number Publication Date
IE872860L true IE872860L (en) 1988-04-24

Family

ID=27427782

Family Applications (1)

Application Number Title Priority Date Filing Date
IE872860A IE872860L (en) 1986-10-24 1987-10-23 Therapeutic compositions and use thereof

Country Status (16)

Country Link
EP (1) EP0265388A1 (pt)
KR (1) KR880005094A (pt)
AT (1) ATA281087A (pt)
BE (1) BE1002060A3 (pt)
DE (1) DE3735641A1 (pt)
DK (1) DK554887A (pt)
FI (1) FI874643A (pt)
FR (1) FR2605629A1 (pt)
GB (1) GB2197315A (pt)
GR (1) GR871634B (pt)
HU (1) HUT45492A (pt)
IE (1) IE872860L (pt)
NL (1) NL8702533A (pt)
NO (1) NO874425L (pt)
PT (1) PT85976B (pt)
SE (1) SE8704093L (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0265388A1 (de) * 1986-10-24 1988-04-27 Ciba-Geigy Ag Pyrrol-Derivate, therapeutische Mittel, die sie enthalten und ihre Verwendung
JPH02131465A (ja) * 1988-07-18 1990-05-21 Nippon Tokushu Noyaku Seizo Kk 1−フエニルピロール類及び除草剤としての利用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204241A1 (es) * 1973-03-09 1975-12-10 Ciba Geigy Ag Procedimiento para preparar compuestos derivados del 1-pirrolil(1)-fenoxi-2-hidroxi-3-alquilamino-propano y del 1-pirrolil-(1)-fenoxi-3-hidroxi-3-morfolino-propano
DE2835438A1 (de) * 1978-08-12 1980-03-06 Basf Ag Aminopropanolderivate des 2-(o-hydroxyphenyl)-pyrrols
EP0152379A3 (de) * 1984-02-15 1986-10-29 Ciba-Geigy Ag Verfahren zur Herstellung von pharmazeutischen Zusammensetzungen enthaltend unilamellare Liposomen
EP0265388A1 (de) * 1986-10-24 1988-04-27 Ciba-Geigy Ag Pyrrol-Derivate, therapeutische Mittel, die sie enthalten und ihre Verwendung

Also Published As

Publication number Publication date
PT85976B (de) 1990-01-19
FR2605629A1 (fr) 1988-04-29
GR871634B (en) 1988-02-24
FI874643A0 (fi) 1987-10-21
SE8704093D0 (sv) 1987-10-21
DK554887D0 (da) 1987-10-23
ATA281087A (de) 1989-01-15
KR880005094A (ko) 1988-06-28
BE1002060A3 (fr) 1990-06-12
PT85976A (de) 1987-11-01
NO874425L (no) 1988-04-25
HUT45492A (en) 1988-07-28
GB2197315A (en) 1988-05-18
DK554887A (da) 1988-04-05
NL8702533A (nl) 1988-05-16
DE3735641A1 (de) 1988-04-28
FI874643A (fi) 1988-04-25
EP0265388A1 (de) 1988-04-27
SE8704093L (sv) 1988-04-25
NO874425D0 (no) 1987-10-23

Similar Documents

Publication Publication Date Title
HUT40143A (en) Process for preparing n,n-dialkyl-guanidino-dipeptide derivatives and pharmaceutical compositions containing thereof as active substances
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
IL57471A (en) Salicylamide derivatives of n-alkylated aminoalcohols and their salts,their preparation and pharmaceutical compositions containing them
IT1235532B (it) Composti carbossiammidici, procedimenti per la preparazione dei medesimi e composizione farmaceutica contenente i medesimi
AU4936890A (en) Medicament containing dihydrolipoic acid as active substance
DE3262536D1 (en) N-dihydrothiazolyl-3-quinoleine carboxyamide derivatives, their salts, their preparation and use as pharmaceutical preparations, and pharmaceutical preparations containing them
IE780503L (en) Pyridinyl aminoalkyl ethers.
HUT41750A (en) Process for preparing 2-hydroxy-4h-3,1-benzazin-4-one derivatives, pharmaceutical compositions containing thereof as active ingredients and intermediers thereof
AU591046B2 (en) Physiologically active agent for agricultural use
EP0199117A3 (en) New therapeutical use of phosphocreatine
AU610175B2 (en) Pharmaceutical composition comprising a compound containing sulfhydryl group(s) for the treatment of otitis
AU5285986A (en) All-cis-1,3,5-triamino-2,4,6-cyclohexanetriol derivatives, their use, processes for their preparation and pharmaceutical preparations containing them
IE872860L (en) Therapeutic compositions and use thereof
AU5649286A (en) New derivatives of 4-phenylpropyl indole and their salts, their preparation process, their use as medicaments and the pharmaceutical compositions containing them
NO860091L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino(4[,5[:3,4)pyrrolo(2,1-a)isokinolin-derivater.
CY1228A (en) Bronchospasmolytically active compounds,processes for their preparation,pharmaceutical preparations containing them and their medicinal use
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
NO870834L (no) Glysero-3(2)-fosfo-l-serinderivater og salter derav, fremgangsmaater for fremstilling derav og farmasoeytiske preparater inneholdende derivatene.
AU578766B2 (en) 1,3,4-Thiadiazole derivatives, processes for their preparation, and pharmaceutical preparations containing these compounds
CA2036592A1 (en) Therapeutic agent for diabetic gangrene
IL76967A (en) 3-(ar)alk-1-en-3-ynyl cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
EP0418065A3 (en) Dihydrocaffeic acid derivatives, use thereof for medical treatments and pharmaceutical preparations containing same
IL89099A0 (en) Hydrazides and hydroxamic acid derivatives,their preparation and their use as herbicides
IE43848L (en) Pharmaceutical compositions
HUT42772A (en) Process for preparing 1,2,3,4,5,6-hexahydroazepino /4,5-b/indole derivatives and pharmaceutical preparations containing such active substance